Table 1.
Demographic, clinical and therapeutic management in patients with Bell’s palsy
| Variable | n /total (%) | |
|---|---|---|
| Age (years/mean ± SD) | 46,87 ± 21,49 | |
| Gender | MaleFemale | 248 (50,1) 247 (49,9) |
| Race | Caucasian Black Missing |
469 (98,9) 5 (1,1) 21 |
| Time of presentation | < 24h 24-48h 48-72h >72h Missing |
307 (68,9) 73 (16,6) 37 (8,4) 23 (5,2) 55 |
| Symptoms | ||
| Sensitive Dysgeusia Cochleovestibular Xerophthalmia Neurological |
234 /436 (53,7) 22 /438 (5) 30 /440 (6,8) 1 /438 (0,2) 49 /441 (11,1) |
|
| Pregnancy | 4 /227 (1,8) | |
| PUAI | 45 /420 (10,7) | |
| Hypertension | 145 /402 (36,1) | |
| Diabetes mellitus 2 | 69 /402 (17,2) | |
| HIV | 3 /402 (0,7) | |
| Autoimmune disease | 9 /402 (2,2) | |
| Previous PFP | 50 /412 (12,1) | |
| CT scan <72h | 157 /495 (31,7) | |
| Laboratory tests | 132 /494 (26,7) | |
| PFP severity | HB 1 HB 2 HB 3 HB 4 HB 5 HB 6 Missing |
12 (3,9) 94 (30,6) 117 (38,1) 67 (21,8) 17 (5,5) 0 188 |
| Referred to | General physician Neurology Otolaryngology Other |
336 (67,9) 58 (11,7) 96 (19,4) 5 (1) |
| Otolaryngology observation | 326 /495 (65,9) | |
| Drug therapy | None SS AV SS + AV Other Missing |
56 (11,7) 327 (68,3) 2 (0,4) 81 (16,9) 13 (2,7) 16 |
HB: House-Brackmann facial grading system; PUAI: Previous Upper Airway Infection; CT scan: Computerized tomography scanning; PFP: Peripheral Facial Palsy; SS: systemic steroids; AV: systemic antiviral